Komori
Stella Pharma (4888) · InitiativeAdvanced

Acquiring and Developing Talent for Global Expansion

First written in FY2021. 2 of 4 entries say "Restated". Latest entry: FY2026.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20252021: 120212022: 120222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies

36 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 66 companies compared. The sentences above are computed from all 66.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「As we pursue the expansion of indications, overseas development, and the strengthening of our manufacturing and supply systems, we will secure the specialized personnel needed in research and development, regulatory affairs, quality assurance, manufacturing, business development and administrative functions, while developing an organizational structure suited to the expansion of our business.」

    Identifies the securing of specialized personnel, including in regulatory affairs, quality assurance, manufacturing and business development, and the development of the organizational structure as specific issues in addition to global expansion.
  2. FY2025RestatedAnnual report

    「Although we operate with a small organization, we recognize that, to expand globally in the future, it is important to recruit highly capable personnel with experience and knowledge of the pharmaceutical industry and to develop our sales, development and administrative structures. We will also place emphasis on internal education and provide training, including induction and continuing education.」

    Reaffirms the recruitment of highly capable personnel, development of sales, development and administrative structures, and induction and continuing education as important issues for global expansion.
  3. FY2022RestatedAnnual report

    「We recognize that, to expand globally in the future, it is important to recruit highly capable personnel with experience and knowledge of the pharmaceutical industry and to develop our sales, development and administrative structures. Alongside our recruitment activities, we will place emphasis on education and training and work to build an organization in which the Company and its employees can grow together.」

    Continuing recruitment, education and training, and the development of sales, development and administrative structures for global expansion.
  4. FY2021First statedAnnual report

    「We recognize that, to expand globally in the future, it is important to recruit highly capable personnel with experience and knowledge of the pharmaceutical industry and to develop our sales, development and administrative structures. Alongside our recruitment activities, we will place emphasis on education and training and work to build an organization in which the Company and its employees can grow together.」

    Uses recruitment, education and training, and the development of sales, development and administrative structures to expand the organization.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Stella Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Acquiring and Developing Talent for Global Expansion | STELLA PHARMA CORPORATION (4888) | Komori